We are live on
!
Find out more
SPA
Sherbrooke Park Advisers Portfolio holdings
AUM
$38.7M
1-Year Est. Return
5.29%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
(+7.3%)
Cap. Flow
+$5.46M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$1.45M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.42M |
| 3 |
Genpact
G
|
+$1.42M |
| 4 |
C.H. Robinson
CHRW
|
+$1.34M |
| 5 |
OGE Energy
OGE
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.44M |
| 2 |
Mondelez International
MDLZ
|
+$1.42M |
| 3 |
Avnet
AVT
|
+$1.21M |
| 4 |
Marvell Technology
MRVL
|
+$1.04M |
| 5 |
XYZ
Block Inc
XYZ
|
+$987K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.25% |
| 2 | Consumer Discretionary | 15.35% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 12.99% |
| 5 | Financials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Priority Technology Holdings
PRTH
$439M
| $84.7K | 0.04% |
+10,892
| New | +$81.8K |
|
477
Stoneridge
SRI
$210M
| $83.4K | 0.04% |
11,852
-17,744
| -60% | -$86.9K |
|
478
Energy Fuels
UUUU
$3.55B
| $77.2K | 0.03% |
+13,432
| New | +$64.5K |
|
|
AHRT
479
AH Realty Trust
AHRT
$510M
| $74.1K | 0.03% |
10,789
-3,033
| -22% | -$21.1K |
|
480
Planet Labs
PL
$8.55B
| $73.6K | 0.03% |
+12,069
| New | +$49.3K |
|
|
KW
481
DELISTED
Kennedy-Wilson Holdings
KW
| $72.4K | 0.03% |
+10,652
| New | +$71K |
|
482
Biote Corp
BTMD
$47M
| $72.2K | 0.03% |
17,968
-6,152
| -26% | -$22.7K |
|
483
CS Disco
LAW
$279M
| $69.7K | 0.03% |
15,947
-9,173
| -37% | -$35.9K |
|
484
MannKind Corp
MNKD
$1.31B
| $68.8K | 0.03% |
18,394
-18,206
| -50% | -$80.2K |
|
|
TEAD
485
Teads Holding Co
TEAD
$69.6M
| $68.4K | 0.03% |
27,579
-20,798
| -43% | -$62.9K |
|
486
Arbutus Biopharma
ABUS
$917M
| $66.8K | 0.03% |
+21,634
| New | +$71.8K |
|
|
CMRC
487
Commerce.com Inc Series 1
CMRC
$178M
| $64.1K | 0.03% |
+12,822
| New | +$66K |
|
488
Rayonier Advanced Materials
RYAM
$607M
| $62.3K | 0.03% |
16,192
-16,570
| -51% | -$69.6K |
|
489
Oil States International
OIS
$510M
| $61.7K | 0.03% |
+11,520
| New | +$51K |
|
490
Ardelyx
ARDX
$1.01B
| $60.9K | 0.03% |
15,529
-36,477
| -70% | -$150K |
|
|
EWCZ
491
DELISTED
European Wax Center
EWCZ
| $59.5K | 0.03% |
+10,561
| New | +$48K |
|
492
Unisys
UIS
$213M
| $59.2K | 0.03% |
13,078
-20,743
| -61% | -$93.3K |
|
493
Recursion Pharmaceuticals
RXRX
$1.78B
| $57.5K | 0.03% |
+11,356
| New | +$55.8K |
|
494
FuboTV Inc
FUBO
$262M
| $55.6K | 0.02% |
+1,200
| New | +$44.9K |
|
495
Clarivate
CLVT
$1.17B
| $54.5K | 0.02% |
+12,673
| New | +$51K |
|
496
Myriad Genetics
MYGN
$313M
| $54K | 0.02% |
10,172
-16,638
| -62% | -$98.3K |
|
497
The RealReal
REAL
$1.47B
| $53.6K | 0.02% |
+11,200
| New | +$61.6K |
|
498
Virgin Galactic
SPCE
$396M
| $52.9K | 0.02% |
19,373
-14,231
| -42% | -$43.6K |
|
499
Frontier Group Holdings
ULCC
$1.64B
| $52.4K | 0.02% |
14,430
-16,980
| -54% | -$62.2K |
|
500
Health Catalyst
HCAT
$129M
| $48.8K | 0.02% |
12,946
-26,590
| -67% | -$105K |
|
Similar funds
2C
SIM
ISSM
KCM
EFI
ICM
APM
CI
Sherbrooke Park Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.
Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
- Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
- Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
- Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
- Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
- Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
- Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.
Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.